Roy Altman1, Asheesh Bedi2, Ajay Manjoo3, Faizan Niazi4, Peter Shaw4, Philip Mease5,6. 1. 1 Division of Rheumatology and Immunology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. 2. 2 Chief of Sports Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA. 3. 3 Department of Orthopedics, McMaster University, Hamilton, Ontario, Canada. 4. 4 Ferring Pharmaceuticals Inc., Parsippany, NJ, USA. 5. 5 Swedish-Providence-St. Joseph's Health Systems, Seattle, WA, USA. 6. 6 University of Washington School of Medicine, Seattle, WA, USA.
Abstract
OBJECTIVE: Osteoarthritis (OA) is one of the leading causes of disability in the adult population. Common nonoperative treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids, and intra-articular injections of hyaluronic acid (HA). HA is found intrinsically within the knee joint providing viscoelastic properties to the synovial fluid. HA therapy provides anti-inflammatory relief through a number of different pathways, including the suppression of pro-inflammatory cytokines and chemokines. METHODS: We conducted a systematic review to summarize the published literature on the anti-inflammatory properties of hyaluronic acid in osteoarthritis. Included articles were categorized based on the primary anti-inflammatory responses described within them, by the immediate cell surface receptor protein assessed within the article, or based on the primary theme of the article. Key findings aimed to describe the macromolecules and inflammatory-mediated responses associated with the cell transmembrane receptors. RESULTS: Forty-eight articles were included in this systematic review that focused on the general anti-inflammatory effects of HA in knee OA, mediated through receptor-binding relationships with cluster determinant 44 (CD44), toll-like receptor 2 (TLR-2) and 4 (TLR-4), intercellular adhesion molecule-1 (ICAM-1), and layilin (LAYN) cell surface receptors. Higher molecular weight HA (HMWHA) promotes anti-inflammatory responses, whereas short HA oligosaccharides produce inflammatory reactions. CONCLUSIONS: Intra-articular HA is a viable therapeutic option in treating knee OA and suppressing inflammatory responses. HMWHA is effective in suppressing the key macromolecules that elicit the inflammatory response by short HA oligosaccharides.
OBJECTIVE:Osteoarthritis (OA) is one of the leading causes of disability in the adult population. Common nonoperative treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids, and intra-articular injections of hyaluronic acid (HA). HA is found intrinsically within the knee joint providing viscoelastic properties to the synovial fluid. HA therapy provides anti-inflammatory relief through a number of different pathways, including the suppression of pro-inflammatory cytokines and chemokines. METHODS: We conducted a systematic review to summarize the published literature on the anti-inflammatory properties of hyaluronic acid in osteoarthritis. Included articles were categorized based on the primary anti-inflammatory responses described within them, by the immediate cell surface receptor protein assessed within the article, or based on the primary theme of the article. Key findings aimed to describe the macromolecules and inflammatory-mediated responses associated with the cell transmembrane receptors. RESULTS: Forty-eight articles were included in this systematic review that focused on the general anti-inflammatory effects of HA in knee OA, mediated through receptor-binding relationships with cluster determinant 44 (CD44), toll-like receptor 2 (TLR-2) and 4 (TLR-4), intercellular adhesion molecule-1 (ICAM-1), and layilin (LAYN) cell surface receptors. Higher molecular weight HA (HMWHA) promotes anti-inflammatory responses, whereas short HAoligosaccharides produce inflammatory reactions. CONCLUSIONS:Intra-articularHA is a viable therapeutic option in treating knee OA and suppressing inflammatory responses. HMWHA is effective in suppressing the key macromolecules that elicit the inflammatory response by short HAoligosaccharides.
Authors: Giuseppe M Campo; Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Vera Prestipino; Alberto Calatroni; Salvatore Campo Journal: Innate Immun Date: 2012-01-25 Impact factor: 2.680
Authors: T Hiramitsu; T Yasuda; H Ito; M Shimizu; S M Julovi; T Kakinuma; M Akiyoshi; M Yoshida; T Nakamura Journal: Rheumatology (Oxford) Date: 2006-01-31 Impact factor: 7.580
Authors: Maria Eduarda Anastácio Borges Corrêa; Carolini Mendes; João Vitor Silvano Bittencourt; Aline Takejima; Isio Carvalho de Souza; Simone Cristina Dizaró de Carvalho; Ingrid Gabriela Orlandini; Thiago Antonio Moretti de Andrade; Luiz César Guarita-Souza; Paulo Cesar Lock Silveira Journal: Ann Biomed Eng Date: 2022-07-08 Impact factor: 3.934
Authors: Anne-Mari Mustonen; Janne Capra; Kirsi Rilla; Petri Lehenkari; Sanna Oikari; Tommi Kääriäinen; Antti Joukainen; Heikki Kröger; Tommi Paakkonen; Johanna Matilainen; Petteri Nieminen Journal: BMC Musculoskelet Disord Date: 2021-03-06 Impact factor: 2.362
Authors: Hala Alkhoury; Adrian Hautmann; Bodo Fuhrmann; Frank Syrowatka; Frank Erdmann; Guoying Zhou; Sanja Stojanović; Stevo Najman; Thomas Groth Journal: Int J Mol Sci Date: 2020-05-25 Impact factor: 5.923